Share

    


Home / Search Results

Search Results

You searched for:

Major takeaways from the NCCN Oncology Policy Summit in Washington D.C. on Tuesday, September 12.
Equitable access to precision medicine should be a right to which all patients with cancer are entitled regardless of their insurance coverage or type. Read more about ACCC’s efforts to help Medicaid beneficiaries overcome financial barriers to biomarker testing.
ACCC recognizes breast cancer awareness month.
ACCC in partnership with HealthTree Foundation for Acute Myeloid Leukemia, has launched an education program to explore the current barriers in care coordination and therapy options for patients with AML who are not eligible for transplant.
ACCC president Olalekan Ajayi, PharmD, MBA, shared the association’s key priorities for impacting cancer care in the United States with the President’s Cancer Panel.
Highlights from the third and final day of #ACCCNOC.
Key takeaways from day 1 of #ACCCNOC.
Let’s Win Pancreatic Cancer provides a road map of resources to help newly diagnosed patients with pancreatic cancer obtain the resources they need throughout their care journey.
The Centers for Medicare and Medicaid Services has recently proposed reimbursement for Principal Illness Navigation services under Medicare to help patients navigate treatment for serious illnesses such as cancer.
This cancer program adapted the University of Washington’s Collaborative Care model to embed counseling services into oncology and palliative care across six clinic locations. This model allows patients to receive counseling for depression, anxiety, or other psycho-social concerns while in active treatment and survivorship, eliminating many barriers to care.
Through a series of education projects, ACCC is committed to providing the resources the multidisciplinary cancer care team will need to navigate the complex precision medicine landscape and deliver next generation cancer care.
In the era of personalized medicine, biomarker testing is a tool the oncology workforce can and should leverage to deliver next generation cancer care.
St. Elizabeth Cancer Center launched a comprehensive program to perform outreach to patients with outstanding orders for lung, breast, and colon cancer screenings.
For patients with pancreatic cancer, clinical trials should be considered as a possible treatment option early on, not a last resort when all else fails. The Let's Win team discusses why.
Recognizing the effects of SDOH on patients and providers is key as studies show they can impact as much as 80% to 90% of health-related outcomes.
To explore the current state of psychosocial care in oncology, ACCC, with its partners, AOSW and APOS, with support from BeiGene—held a multistakeholder meeting, ACCC’s Call to Action: Delivery of Psychosocial Care in Oncology Summit.
ACCC is working with multidisciplinary care teams to assess the impact of SDOH on equitable access to cancer care and clinical trials among minority populations.
For National Pride Month this year, the Association of Community Cancer Centers (ACCC) is highlighting the transgender community and what it means for cancer programs and practices nationwide to provide trans-inclusive care.
National Black Family Cancer Awareness Week is dedicated to raising awareness of the importance of clinical trial participation and specimen donations for cancer research among Black Americans.
Let’s Win Pancreatic Cancer is an advocacy organization that works with patients, providers, and researchers to share the latest information and treatment options for pancreatic cancer.